Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 49.1 to 43.1.
Financials
Financial year 2025
Laboratoires de Biologie Médicale Bauduin from Enghien, company number BE0417157111, closed financial year 2025 with a result of € -508,405 after tax. For that financial year Laboratoires de Biologie Médicale Bauduin recorded revenue of € 8.4 million and equity of € 728,397. Compared with financial year 2024, the result moved from € -1.4 million to € -508,405. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 728,397
▼ 41% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -508,405
▲ 63 % less loss than in 2024
Profit after tax over the fiscal year.
€ 316,016
▲ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.3 million.
People and assets in 2025
43.1
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.9 million
▲ 1% vs 2024
€ 68,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 36,011
▼ 9% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.2 million
▲ 32% vs 2024
€ 27,931 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 821,860
▲ 3% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 52 days on average.
€ 656,213
▲ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 8,808,456 | € 8,226,606 | € 7,631,187 | € 8,410,115 | ▲ 10% |
| Profit after taxes | € -1,345,551 | € -1,151,290 | € -1,386,729 | € -508,405 | ▲ € 878,325 |
| Equity | € 3,774,821 | € 2,623,531 | € 1,236,801 | € 728,397 | ▼ 41% |
| Total debts | € 2,424,431 | € 2,025,838 | € 2,370,444 | € 2,720,971 | ▲ 15% |
| Cash | € 542,107 | € 437,097 | € 295,331 | € 316,016 | ▲ 7% |
| Land & buildings | € 26,050 | € 533,632 | € 507,820 | € 482,008 | ▼ 5% |
| Retained profit | € 1,754,821 | € 603,531 | € -783,199 | € -1,291,603 | ▼ € 508,405 |
| Bank debt | € 0 | € 512,713 | € 916,903 | € 1,210,043 | ▲ 32% |
| Balance sheet total | € 6,199,252 | € 4,649,369 | € 3,607,245 | € 3,449,368 | ▼ 4% |
| Employees (FTE) | 53.1 | 49.1 | 43.5 | 43.1 | ▼ 0.4 |
Key figures of Laboratoires de Biologie Médicale Bauduin, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Laboratoires de Biologie Médicale Bauduin?
What happened at Laboratoires de Biologie Médicale Bauduin in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 508,405. Source: NBB ↗
- Labo M.D. SRL became a director. NBB
- New establishment in Enghien. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.3 million loss in 2022 to € 508,405 loss in 2025.
Paid € 2,720 in corporate taxes since 2022.
Pays suppliers within 52 days on average.
A new publication or filing at Laboratoires de Biologie Médicale Bauduin? We notify you, reason included.
Follow Laboratoires de Biologie Médicale BauduinDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Laboratoires de Biologie Médicale Bauduin is Labo M.D. SRL.
Directors
According to the 2025 annual accounts
Director · represented by Maxime Depoorter
since 2023
Establishments
Establishment units
Physical locations of this company
Val Lise Square(P.E.) 7
7850 Enghien
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0417.157.111
- VAT number
- BE 0417.157.111
- Registered office
- Val Lise Square(P.E.) 7, 7850 Enghien
- Names & denominations
- Laboratoires de Biologie Médicale Bauduin
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 December 1976
- Peppol
- Active · Active since 28 May 2026
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria
Overige technische testen en toetsen